মগজুৰ টিউমাৰ (মেডুল'ব্লাষ্ট'মা)
Systemic Biomarkers to Predict Radiation-Induced Neurocognitive Decline
ক’ত যাব
ভাৰতৰ 1 খন হস্পিতালত এই trial-ৰ বাবে ৰোগী ভৰ্তি কৰা হৈছে।
ৰেজিষ্ট্ৰীৰ সাৰাংশ (কাৰিকৰী)
Radiation constitutes an integral component in the management of primary brain tumors in pediatric and young adults like medulloblastoma, ependymoma, low-grade glioma, pituitary tumors, etc. A decline in neurocognitive outcomes is a multifactorial effect occurring from the primary disease as well as associated with treatments, including radiation. Since many of these tumors are highly curable, it is crucial to reduce long-term side effects, including memory loss, to improve the quality of life in these patients, leading to better rehabilitation. Radiation-induced neurocognitive deterioration i…
স্পনছৰ: টাটা মেম'ৰিয়েল চেণ্টাৰ
ClinicalTrials.gov ত NCT06779487
ৰেজিষ্ট্ৰীত শেষ আপডেট 11 Apr 2025 · আমাৰ দ্বাৰা পঢ়া হৈছে 20 Oct 2026